IFNG and neoplasm: This provides evidence that IFNγ is involved in a negative feedback loop in melanoma to limit anti-tumor immunity by restricting stem-like T cell longevity, offering new strategies to enhance stem-like T cell potential in tumors and potentially improve adoptive T cell transfer therapies.